ESI Senior Advisor Dr. Joseph P. Fuhr, Jr. moderated a panel for the 9th Annual Summit on Biosimilars presented by CBI on March 20th, 2014. The panel discussed the best practices to jointly oversee brand and biosimilars products.
CBI is a leader in conferences for the pharmaceutical industry. CBI conferences are life science leaders in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device, and healthcare industries.